Sandler Capital Management Dexcom Inc Transaction History

Sandler Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $723,372 - $969,133	-9,274 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $1.25 Million - $1.48 Million	-13,116 Reduced 58.58%	9,274 $3.82 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $525,885 - $883,802	8,390 Added 59.93%	22,390 $9.08 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $669,060 - $1.06 Million	14,000 New	14,000 $3.77 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $1.02 Million - $1.43 Million	-36,780 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $1.03 Million - $1.4 Million	36,780 New	36,780 $4.38 Million

1,080

351M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $35.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

Stay updated on Sandler Capital Management with notifications on news.